Advisory Services Network’s Immunomedics Inc IMMU Stock Holding History

Advisory Services Network’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-47,604	Closed	-$4.05M	–	3937
2020 Q3	$4.05M	Buy	47,604 +37,668	+379%	+$1.9M	0.19%	132
2020 Q2	$352K	Buy	9,936 +6,709	+208%	+$196K	0.02%	735
2020 Q1	$43K	Hold	3,227	–	–	﹤0.01%	1467
2019 Q4	$68K	Buy	3,227 +100	+3%	+$1.76K	﹤0.01%	1355
2019 Q3	$43K	Hold	3,127	–	–	﹤0.01%	1442
2019 Q2	$43K	Hold	3,127	–	–	﹤0.01%	1440
2019 Q1	$60K	Hold	3,127	–	–	﹤0.01%	1179
2018 Q4	$45K	Hold	3,127	–	–	﹤0.01%	1192
2018 Q3	$65K	Buy	3,127 +55	+2%	+$1.3K	﹤0.01%	1133
2018 Q2	$73K	Hold	3,072	–	–	0.01%	1081
2018 Q1	$45K	Hold	3,072	–	–	﹤0.01%	1366
2017 Q4	$50K	Buy	3,072 +1,072	+54%	+$12.7K	﹤0.01%	1277
2017 Q3	$28K	Hold	2,000	–	–	﹤0.01%	1305
2017 Q2	$18K	Buy	+2,000	New	+$14K	﹤0.01%	1390

Advisory Services Network's IMMU Position: Q4 2020 in Review

Advisory Services Network sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 47,604 shares — an estimated $4.05M sold.

Advisory Services Network first reported a position in IMMU in Q2 2017 and held it in 14 quarters. The position peaked at $4.05M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Advisory Services Network reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Advisory Services Network sold 47,604 Immunomedics Inc shares in Q4 2020, an estimated $4.05M.
Advisory Services Network first reported a position in Immunomedics Inc in Q2 2017 and held it in 14 quarters.
Advisory Services Network's Immunomedics Inc position peaked at $4.05M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.